drugset / Trial / NCT00298285
ABRIDGE: Low Molecular Weight Heparin in Bridging Patients After Mechanical Valve Replacement
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The primary aim is to determine the rate of major bleeding and blood clots when using enoxaparin as a bridge to oral blood thinning medication in patients who have undergone mechanical valve replacement.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- 2006-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Enoxaparin sodium | Other / unclassified | — | Other |
Indications
No indication recorded.